A detailed history of Bsn Capital Partners LTD transactions in Eli Lilly & CO stock. As of the latest transaction made, Bsn Capital Partners LTD holds 18,000 shares of LLY stock, worth $14.3 Million. This represents 3.27% of its overall portfolio holdings.

Number of Shares
18,000
Holding current value
$14.3 Million
% of portfolio
3.27%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$772.14 - $960.02 $13.9 Million - $17.3 Million
18,000 New
18,000 $16.8 Billion
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $26.7 Million - $31.1 Million
83,000 New
83,000 $30.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bsn Capital Partners LTD Portfolio

Follow Bsn Capital Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bsn Capital Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Bsn Capital Partners LTD with notifications on news.